Information  X 
Enter a valid email address

Manolete Partners (MANO)


Tuesday 26 April, 2022

Manolete Partners

Update to recent Trading Statement & cash receipt

RNS Number : 2609J
Manolete Partners PLC
26 April 2022

Manolete Partners Plc

("Manolete" or the "Company")


Update to recent Trading Statement and confirmation of cash receipt



In the trading statement released on 11 April 2022, Manolete Partners Plc (AIM: MANO), the leading listed insolvency litigation financing firm in the UK , referenced the completion of one of its larger case investments for £9.5 million, of which Manolete's share would be £5.6 million, and that the cash was due to be received in the near future. The Board can now confirm that all expected cash has been received.


Steven Cooklin, CEO of Manolete commented:


"I am pleased to report that the cash due to us, from this large investment, was received on schedule, within three weeks of the legal completion of the case. Our net debt position is now down to £6.5 million, and with new case enquiries rebounding sharply upwards following the challenges of Omicron, we look forward to further strong progress."



For further information, please contact:

Manolete Partners Plc  

via Instinctif Partners

Steven Cooklin (Chief Executive Officer)




Peel Hunt (NOMAD and Sole Broker)

+44 (0)20 7418 8900

James Britton


Rishi Shah




Instinctif Partners (Financial PR)


Tim Linacre

+44 (0)7949 939237


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t